SHORT COUPLED TORSADES DE POINTES
Short Coupled Torsades De Point is a rare condition that can lead to a potentially fatal heart rhythm called ventricular tachycardia. Although doctors and researchers at New York Presbyterian Hospital have made great strides in genetic research a solution is still out of reach. With proper diagnosis and treatment, the condition can be managed but ground breaking stem-cell genetic research being led by Dr. Jim Cheung of NY Presbyterian Hospital in associate with Dr. Todd Evans of NY Stem and Dr. Albano Meli in France is the future answer.
Just one frontier for stem cell research is finding a cure for acute heart conditions. Around 280,000 people die every year from cardiac arrest, and many of those people will die with no warning and no prior history of heart disease. Research into the cause of cardiac arrest is difficult – studying the genetic mutations that cause these cardiac arrests is all but impossible, as most carrying the mutation will never know they have it. But new stem cell technology allows doctors to use blood cells from an affected adult to grow both healthy and diseased tissue, giving scientists an opportunity to study the disease and trial potential cures.
To learn more, read this article published in the Weill Cornell Medical College, NY-Presbyterian Hospital 2013 Annual Report about the Discovery of a Novel Genetic Mutation Linked to Life-threatening Arrhythmias in Structurally Normal Hearts, citing the research being done on the Singh family. Watch Praveen tell her story and learn more about the research underway, from the research team.
For more details about the research, read Characterization of DMD and CPVT Patient-Specific Cardiomyocytes Derived From Induced Pluripotent Stem Cells.
TO DONATE: Click the button below. From our family to yours, thank you for your support!
#GivingTuesday #GoRed
